quinazolines has been researched along with Gingivitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodor, C; Dinya, E; Győrfi, A; Gyurkovics, M; Lohinai, Z; Rosivall, L; Székely, AD | 1 |
| Iwasaki, H; Kawashima, Y; Kobayashi, H; Kono, Y; Nashimoto, M | 1 |
1 trial(s) available for quinazolines and Gingivitis
| Article | Year |
|---|---|
[Evaluation of SL-573 in acute purulent diseases in the field of orodental surgery--a double-blind method in comparison with mepirizole].
Topics: Acute Disease; Adult; Double-Blind Method; Drug Evaluation; Epirizole; Female; Gingivitis; Humans; Male; Middle Aged; Pyrazoles; Quinazolines; Suppuration | 1979 |
1 other study(ies) available for quinazolines and Gingivitis
| Article | Year |
|---|---|
Microvascular regulatory role and increased expression of vascular endothelial growth factor receptor type 2 in experimental gingivitis.
Topics: Animals; Capillary Permeability; Endothelium, Vascular; Gingiva; Gingivitis; Male; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Pericytes; Quinazolines; Random Allocation; Rats; Rats, Wistar; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasoconstrictor Agents; Vasodilator Agents; Venules | 2013 |